Device type · GXQ
Dura Substitute
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
GXQ
Neurology
Device class
Class II
FDA decisions since 2015
14
510(k), De Novo and PMA
Adverse event reports
61
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Dura Substitute
- Product code
- GXQ
- Device class
- Class II
- Review panel
- Neurology
- Regulation
- 21 CFR 882.5910
- Specialty
- Neurology & Neurosurgery
- FDA record
- Classification database entry for GXQ
Latest FDA decisions
The 8 newest of 14 since 2015.
Synovis Life Technologies, Inc. (Baxter International Inc.)
K260431 · Decided Nov 5, 2026 · 282 days after receipt
Device type: Dura Substitute (GXQ) · Neurology & Neurosurgery
K251191 · Decided Nov 18, 2025 · 215 days after receipt
Device type: Dura Substitute (GXQ) · Neurology & Neurosurgery
K250420 · Decided May 14, 2025 · 90 days after receipt
Device type: Dura Substitute (GXQ) · Neurology & Neurosurgery
- ArtiFascia510(k)
K223445 · Decided Aug 10, 2023 · 269 days after receipt
Device type: Dura Substitute (GXQ) · Neurology & Neurosurgery
- SyntheCel Dura Repair510(k)
K212943 · Decided Jan 28, 2022 · 135 days after receipt
Device type: Dura Substitute (GXQ) · Neurology & Neurosurgery
K183513 · Decided Jun 13, 2019 · 177 days after receipt
Device type: Dura Substitute (GXQ) · Neurology & Neurosurgery
- Cerafix Dura Substitute510(k)
K172603 · Decided Nov 27, 2017 · 89 days after receipt
Device type: Dura Substitute (GXQ) · Neurology & Neurosurgery
Integra LifeSciences Corporation
K163456 · Decided Jan 6, 2017 · 28 days after receipt
Device type: Dura Substitute (GXQ) · Neurology & Neurosurgery
Reports received
61
Received Nov 1, 2025 to Nov 19, 2026. Includes 9 of another or unstated type.
Malfunction reports
5
8.2% of reports
Injury reports
45
74% of reports
Death reports
2
3.3% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 2 | 6 | 1 | 0 |
| Jan 24 | 1 | 4 | 0 | 0 |
| Feb 24 | 1 | 6 | 0 | 0 |
| Mar 24 | 1 | 8 | 0 | 0 |
| Apr 24 | 1 | 4 | 0 | 0 |
| May 24 | 0 | 4 | 0 | 0 |
| Jun 24 | 0 | 4 | 0 | 0 |
| Jul 24 | 0 | 1 | 0 | 0 |
| Aug 24 | 0 | 5 | 0 | 0 |
| Sep 24 | 0 | 4 | 0 | 0 |
| Oct 24 | 0 | 4 | 1 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 0 | 6 | 0 | 0 |
| Jan 25 | 0 | 2 | 0 | 0 |
| Feb 25 | 0 | 1 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 1 | 16 | 0 | 0 |
| May 25 | 0 | 3 | 0 | 0 |
| Jun 25 | 0 | 2 | 1 | 0 |
| Jul 25 | 0 | 10 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 1 | 2 | 0 | 0 |
| Oct 25 | 0 | 10 | 0 | 0 |
| Nov 25 | 0 | 3 | 0 | 0 |
| Dec 25 | 1 | 8 | 2 | 0 |
| Jan 26 | 0 | 7 | 0 | 0 |
| Feb 26 | 2 | 5 | 0 | 0 |
| Mar 26 | 1 | 3 | 0 | 0 |
| Apr 26 | 0 | 2 | 0 | 0 |
| May 26 | 1 | 3 | 0 | 0 |
| Jun 26 | 0 | 1 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 1 |
| Aug 26 | 0 | 0 | 0 | 7 |
| Sep 26 | 0 | 13 | 0 | 1 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Adverse Event Without Identified Device or Use Problem24
- Calcified7
- Material Puncture/Hole7
- Insufficient Device Problem Information4
- Material Disintegration4
- Lack of Effect3
- Adhesive Too Strong2
- Material Deformation2
- Material Split, Cut or Torn2
- Break1
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Cerebrospinal Fluid Leakage18
- Calcium Deposits/Calcification8
- Meningitis8
- Headache6
- Insufficient Information5
- No Clinical Signs, Symptoms or Conditions4
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available3
- Failure of Implant3
- Unspecified Infection3
- Abscess2
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0834-2025 · Started Nov 22, 2024 · Posted by FDA Jan 10, 2025
Reason given: Incorrect version of IFU was used rather than updated version; and incorrect expiration date was used on two of the products.
Cause as FDA categorized it: Under Investigation by firm
Z-0262-2025 · Started Sep 26, 2024 · Posted by FDA Oct 30, 2024
Reason given: Out of specification endotoxin levels.
Cause as FDA categorized it: Nonconforming Material/Component
Z-2207-2023 · Started Jun 13, 2023 · Posted by FDA Jul 20, 2023
Reason given: Dura regeneration matrix may have out-of-specification endotoxin levels due to issues with in-process and finished goods endotoxin testing, which may present clinically with signs and symptoms of an acute inflammatory process, comparable to infection.
Cause as FDA categorized it: Process change control
Z-0668-2022 · Started Dec 13, 2021 · Posted by FDA Feb 24, 2022
Reason given: Outer packaging (outer pouch) is not sealed compromising sterility and result in potential risk of patient infection, which could lead to revision surgery
Cause as FDA categorized it: Nonconforming Material/Component
Z-0669-2022 · Started Dec 13, 2021 · Posted by FDA Feb 24, 2022
Reason given: Outer packaging (outer pouch) is not sealed compromising sterility and result in potential risk of patient infection, which could lead to revision surgery
Cause as FDA categorized it: Nonconforming Material/Component
Z-1383-2016 · Started Dec 8, 2015
Reason given: It was reported that the SYNTHECEL Dura Repair could adhere to various anatomical structures post implantation, which may expose patients to potential risks in the event a surgeon intends to temporarily apply and subsequently remove a SYNTHECEL implant. SYNTHECEL Dura Repair labeling and promotional material are being...
Cause as FDA categorized it: Labeling False and Misleading
Z-1384-2016 · Started Dec 8, 2015
Reason given: It was reported that the SYNTHECEL Dura Repair could adhere to various anatomical structures post implantation, which may expose patients to potential risks in the event a surgeon intends to temporarily apply and subsequently remove a SYNTHECEL implant. SYNTHECEL Dura Repair labeling and promotional material are being...
Cause as FDA categorized it: Labeling False and Misleading
Z-1385-2016 · Started Dec 8, 2015
Reason given: It was reported that the SYNTHECEL Dura Repair could adhere to various anatomical structures post implantation, which may expose patients to potential risks in the event a surgeon intends to temporarily apply and subsequently remove a SYNTHECEL implant. SYNTHECEL Dura Repair labeling and promotional material are being...
Cause as FDA categorized it: Labeling False and Misleading
Showing the 8 newest of 23 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.